The Impact of Public Health Organization and Political Figure Message Sources on Reactions to Coronavirus Prevention Messages

Posted on by

American Journal of Preventive Medicine
January 2021 Volume 60 Issue 1 p1-150
http://www.ajpmonline.org/current

 

Current Issues
The Impact of Public Health Organization and Political Figure Message Sources on Reactions to Coronavirus Prevention Messages
Marcella H. Boynton, Ross E. O’Hara, Howard Tennen,
Joseph G.L. Lee
Published online: August 27, 2020
p136-138

Human Rights Advocacy and Us, the Next Generation of Public Health Leaders

Posted on by

American Journal of Public Health
December 2020 110(12)
http://ajph.aphapublications.org/toc/ajph/current

 

STUDENT PERSPECTIVES ON COVID-19
Human Rights Advocacy and Us, the Next Generation of Public Health Leaders
Human Rights, Social Science, Public Health Practice
Hanna E. Huffstetler, Tamira Daniely, Meredith Dockery, Tsion Ghedamu, Lenore Hango, Ashley Huff, Victoria Matus, Hannah Rice, Sonam J. Shah, Sonam K. Shah, Niharika Soni and Caitlin R. Williams
111(1), pp. 74–76

Artificial Intelligence, Intersectionality, and the Future of Public Health

Posted on by

American Journal of Public Health
December 2020 110(12)
http://ajph.aphapublications.org/toc/ajph/current

 

INTERSECTIONALITY
Artificial Intelligence, Intersectionality, and the Future of Public Health
Other Race/Ethnicity, Human Rights, Statistics/Evaluation/Research, Epidemiology, Ethics, Race/Ethnicity, Gender, Other Statistics/Evaluation/Research
Greta R. Bauer and Daniel J. Lizotte
111(1), pp. 98–100

Preventing the Spread of COVID-19 in Immigration Detention Centers Requires the Release of Detainees

Posted on by

American Journal of Public Health
December 2020 110(12)
http://ajph.aphapublications.org/toc/ajph/current

 

LAW & ETHICS
Preventing the Spread of COVID-19 in Immigration Detention Centers Requires the Release of Detainees
William D. Lopez, Nolan Kline, Alana M. W. LeBrón, Nicole L. Novak, Maria-Elena De Trinidad Young, Gregg Gonsalves, Ranit Mishori, Basil A. Safi and Ian M. Kysel
111(1), pp. 110–115

The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018–2019)

Posted on by

Expert Review of Vaccines
Vol 19 (11) 2020
https://www.tandfonline.com/toc/ierv20/current

 

Review
The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018–2019)
Paolo Bonanni, Pascaline Faivre, Pier Luigi Lopalco, Elmar A. Joura, Tobias Bergroth, Stefan Varga, Nathalie Gemayel & Rosybel Drury
Pages: 1073-1083
Published online: 14 Dec 2020

Statistical power in COVID-19 case-control host genomic study design

Posted on by

Genome Medicine
https://genomemedicine.biomedcentral.com/articles
[Accessed 2 Jan 2021]

 

Statistical power in COVID-19 case-control host genomic study design
The identification of genetic variation that directly impacts infection susceptibility to SARS-CoV-2 and disease severity of COVID-19 is an important step towards risk stratification, personalized treatment pl…
Authors: Yu-Chung Lin, Jennifer D. Brooks, Shelley B. Bull, France Gagnon, Celia M. T. Greenwood, Rayjean J. Hung, Jerald Lawless, Andrew D. Paterson, Lei Sun and Lisa J. Strug
Citation: Genome Medicine 2020 12:115
Content type: Correspondence
Published on: 28 December 2020

Characterizing ‘health equity’ as a national health sector priority for maternal, newborn, and child health in Ethiopia

Posted on by

Global Health Action
Volume 14, Issue 1 (2021)
https://www.tandfonline.com/toc/zgha20/current?nav=tocList

 

Article
Characterizing ‘health equity’ as a national health sector priority for maternal, newborn, and child health in Ethiopia
Nicole Bergen, Arne Ruckert, Lakew Abebe, Shifera Asfaw, Getachew Kiros, Abebe Mamo, Sudhakar Morankar, Manisha A. Kulkarni & Ronald Labonté
Article: 1853386
Published online: 30 Dec 2020

Integrating the social sciences in epidemic preparedness and response: A strategic framework to strengthen capacities and improve Global Health security

Posted on by

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 2 Jan 2021]

 

Research
Integrating the social sciences in epidemic preparedness and response: A strategic framework to strengthen capacities and improve Global Health security
Authors: Kevin Louis Bardosh, Daniel H. de Vries, Sharon Abramowitz, Adama Thorlie, Lianne Cremers, John Kinsman and Darryl Stellmach
30 December 2020

Disability inclusion in humanitarian action

Posted on by

Humanitarian Exchange Magazine
Number 78, October 2020
https://odihpn.org/magazine/inclusion-of-persons-with-disabilities-in-humanitarian-action-what-now/

 

Disability inclusion in humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange, co-edited with Sherin Alsheikh Ahmed from Islamic Relief Worldwide, is disability inclusion in humanitarian action. Persons with disabilities are not only disproportionately impacted by conflicts, disasters and other emergencies, but also face barriers to accessing humanitarian assistance. At the same time, global commitments and standards and the IASC Guidelines on the inclusion of persons with disabilities in humanitarian action all emphasise how persons with disabilities are also active agents of change. Disability and age-focused organisations have led on testing and demonstrating how inclusion can be done better. Yet despite this progress, challenges to effective inclusion remain.

As Kirstin Lange notes in the lead article, chief among these challenges is humanitarian agencies’ lack of engagement with organisations of persons with disabilities. Simione Bula, Elizabeth Morgan and Teresa Thomson look at disability inclusion in humanitarian response in the Pacific, and Kathy Al Jubeh and Alradi Abdalla argue for a ‘participation revolution’, building on learning from the gender movement. Tchaurea Fleury and Sulayman AbdulMumuni Ujah outline how the Bridge Article 11 training initiative is encouraging constructive exchange between humanitarian and disability actors. The lack of good, disaggregated data is highlighted by Sarah Collinson; Frances Hill, Jim Cranshaw and Carys Hughes emphasise the need for training resources in local languages and accessible formats; and Sophie Van Eetvelt and colleagues report on a review of the evidence on inclusion of people with disabilities and older people.

Rebecca Molyneux and co-authors analyse the findings of a review of a DFID programme in north-east Nigeria, while Carolin Funke highlights the importance of strategic partnerships between disability-focused organisations, drawing on her research in Cox’s Bazar. Sherin Alsheikh Ahmed describes Islamic Relief Worldwide’s approach to mainstreaming protection and inclusion, while Pauline Thivillier and Valentina Shafina outline IRC’s Client Responsive Programming. The edition ends with reflections by Mirela Turcanu and Yves Ngunzi Kahashi on CAFOD’s SADI approach.

Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases

Posted on by

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 16, Issue 11, 2020
http://www.tandfonline.com/toc/khvi20/current

 

Article
Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases
Neha Puri, Eric A. Coomes, Hourmazd Haghbayan & Keith Gunaratne
Pages: 2586-2593
Published online: 21 Jul 2020

Determinants of low uptake of vaccination against influenza, measles, and hepatitis B among healthcare professionals in Greece: a multicenter cross-sectional study

Posted on by

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 16, Issue 11, 2020
http://www.tandfonline.com/toc/khvi20/current

 

Article
Determinants of low uptake of vaccination against influenza, measles, and hepatitis B among healthcare professionals in Greece: a multicenter cross-sectional study
Olga Vrachnaki, Eleni Vergadi, Eleni Ioannidou & Emmanouil Galanakis
Pages: 2663-2669
Published online: 13 May 2020

Dengue vaccines: the road to failure or to success?

Posted on by

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 16, Issue 11, 2020
http://www.tandfonline.com/toc/khvi20/current

 

article commentary
Dengue vaccines: the road to failure or to success?
Stanley A. Plotkin
Pages: 2677-2679
Published online: 19 May 2020
A licensed vaccine against dengue was shown to enhance disease under some circumstances, even though it protected most vaccinees. We discuss the implication of these results for the future of dengue vaccines.

Meningococcal infections among refugees and immigrants: silent threats of past, present and future

Posted on by

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 16, Issue 11, 2020
http://www.tandfonline.com/toc/khvi20/current

 

Review
Meningococcal infections among refugees and immigrants: silent threats of past, present and future
Ener Cagri Dinleyici & Ray Borrow on behalf of Global Meningococcal Initiative
Pages: 2781-2786
Published online: 29 Apr 2020

Review of long term immunogenicity and tolerability of live hepatitis A vaccine

Posted on by

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 16, Issue 11, 2020
http://www.tandfonline.com/toc/khvi20/current

 

Review of long term immunogenicity and tolerability of live hepatitis A vaccine
Nitin Shah, MMA Faridi, Monjori Mitra, Ashish Bavdekar, Archana Karadkhele, Gaurav Puppalwar & Rishi Jain
Pages: 2816-2821
Published online: 03 Apr 2020

Pathway towards an ideal and sustainable framework agreement for the public procurement of vaccines in Spain: a multi-criteria decision analysis

Posted on by

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 16, Issue 11, 2020
http://www.tandfonline.com/toc/khvi20/current

 

Article
Pathway towards an ideal and sustainable framework agreement for the public procurement of vaccines in Spain: a multi-criteria decision analysis
N. Zozaya González, B. Alcalá Revilla, P. Arrazola Martínez, J. R. Chávarri Bravo, I. Cuesta Esteve, A. J. García Rojas, F. Martinón-Torres, E. Redondo Margüello, A. Rivero Cuadrado, S. Tamames Gómez, J. Villaseca Carmena & A. Hidalgo-Vega
Pages: 2873-2884
Published online: 03 Apr 2020

Mandating COVID-19 Vaccines

Posted on by

JAMA Network
COVID-19 Update January 2, 2021

 

These articles on COVID-19 were published across the JAMA Network in the last week.
Selected Articles
Opinion
Mandating COVID-19 Vaccines
Lawrence O. Gostin, JD; Daniel A. Salmon, MPH, PhD; Heidi J. Larson, PhD
…From EUAs to BLA Approvals
Mandating COVID-19 vaccines under an EUA is legally and ethically problematic. The act authorizing the FDA to issue EUAs requires the secretary of the Department of Health and Human Services (HHS) to specify whether individuals may refuse the vaccine and the consequences for refusal. Vaccine mandates are unjustified because an EUA requires less safety and efficacy data than full Biologics License Application (BLA) approval. Individuals would also likely distrust vaccine mandates under emergency use, viewing it as ongoing medical research.
Should SARS-CoV-2 Vaccines Be Mandatory?
Once SARS-CoV-2 vaccines receive a BLA, policy makers must determine to which, if any, populations mandates should apply. Vaccine mandates could be imposed in multiple sectors, each with their own legal and ethical considerations…

Willingness to Vaccinate Children against Influenza after the Coronavirus Disease 2019 Pandemic

Posted on by

Journal of Pediatrics
January 2021 Volume 228 p1-326
http://www.jpeds.com/current

 

Original Articles
Willingness to Vaccinate Children against Influenza after the Coronavirus Disease 2019 Pandemic
Ran D. Goldman, Sophie McGregor, Shashidhar R. Marneni,…Samina Ali, Julie C. Brown
andfor the International COVID-19 Parental Attitude Study (COVIPAS) Group
Published online: August 06, 2020
p87-93.e2

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials

Posted on by

The Lancet
Jan 02, 2021 Volume 397 Number 10268 p1-70, e1
https://www.thelancet.com/journals/lancet/issue/current

 

Articles
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials
Xavier Sáez-Llorens, et al
Open Access

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials

Posted on by

The Lancet
Jan 02, 2021 Volume 397 Number 10268 p1-70, e1
https://www.thelancet.com/journals/lancet/issue/current

 

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials
Ilse De Coster, et al
Open Access

Development and dissemination of infectious disease dynamic transmission models during the COVID-19 pandemic: what can we learn from other pathogens and how can we move forward?

Posted on by

Lancet Digital Health
Jan 2021 Volume 3 Number 1 e1-e66
https://www.thelancet.com/journals/landig/issue/current

 

Review
Development and dissemination of infectious disease dynamic transmission models during the COVID-19 pandemic: what can we learn from other pathogens and how can we move forward?
Alexander D Becker, yra H Grantz, Sonia T Hegde, Sophie Bérubé, Derek A T Cummings, Amy Wesolowski

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Posted on by

Lancet Infectious Diseases
Jan 2021 Volume 21 Number 1 p1-148, e1-e16
https://www.thelancet.com/journals/laninf/issue/current

 

Articles
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Shengli Xia, et al

Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis

Posted on by

Lancet Infectious Diseases
Jan 2021 Volume 21 Number 1 p1-148, e1-e16
https://www.thelancet.com/journals/laninf/issue/current

 

Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis
Daniel J Weiss, et al
Open Access

Epidemiology of varicella among immigrants and non-immigrants in Quebec, Canada, before and after the introduction of childhood varicella vaccination: a retrospective cohort study

Posted on by

Lancet Infectious Diseases
Jan 2021 Volume 21 Number 1 p1-148, e1-e16
https://www.thelancet.com/journals/laninf/issue/current

 

Epidemiology of varicella among immigrants and non-immigrants in Quebec, Canada, before and after the introduction of childhood varicella vaccination: a retrospective cohort study
Christina Greenaway, et al

Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study

Posted on by

Lancet Infectious Diseases
Jan 2021 Volume 21 Number 1 p1-148, e1-e16
https://www.thelancet.com/journals/laninf/issue/current

Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study
Stefanie Desmet, et al

Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study

Posted on by

Lancet Infectious Diseases
Jan 2021 Volume 21 Number 1 p1-148, e1-e16
https://www.thelancet.com/journals/laninf/issue/current

 

Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study
Naïm Ouldali, et al

Ethical and Legal Implications of Remote Monitoring of Medical Devices

Posted on by

The Milbank Quarterly
A Multidisciplinary Journal of Population Health and Health Policy

Ethical and Legal Implications of Remote Monitoring of Medical Devices
I. GLENN COHEN, SARA GERKE, DANIEL B. KRAMER

 

Pages: 1257-1289
First Published: 20 October 2020
Abstract
Policy Points
:: Millions of life‐sustaining implantable devices collect and relay massive amounts of digital health data, increasingly by using user‐downloaded smartphone applications to facilitate data relay to clinicians via manufacturer servers.
:: Our analysis of health privacy laws indicates that most US patients may have little access to their own digital health data in the United States under the Health Insurance Portability and Accountability Act Privacy Rule, whereas the EU General Data Protection Regulation and the California Consumer Privacy Act grant greater access to device‐collected data.
:: Our normative analysis argues for consistently granting patients access to the raw data collected by their implantable devices.

A Commons for a Supply Chain in the Post‐COVID‐19 Era: The Case for a Reformed Strategic National Stockpile

Posted on by

The Milbank Quarterly
A Multidisciplinary Journal of Population Health and Health Policy

 

Volume 98, Issue 4 Pages: 1021-1341, E1-E12 December 2020
https://onlinelibrary.wiley.com/toc/14680009/current
Original Scholarship
Free Access
A Commons for a Supply Chain in the Post‐COVID‐19 Era: The Case for a Reformed Strategic National Stockpile
ROBERT HANDFIELD, DANIEL JOSEPH FINKENSTADT, EUGENE S. SCHNELLER, A. BLANTON GODFREY
PETER GUINTO
Pages: 1058-1090
First Published: 02 November 2020

Genetics meets proteomics: perspectives for large population-based studies

Posted on by

Nature Reviews Genetics
Volume 22 Issue 1, January 2021
https://www.nature.com/nrg/volumes/22/issues/1

 

Review Article | 28 August 2020
Genetics meets proteomics: perspectives for large population-based studies
In this Review, Suhre, McCarthy and Schwenk describe how combining genetics with plasma proteomics is providing notable insights into human disease. As changes in the circulating proteome are often an intermediate molecular readout between a genetic variant and its organismal effect, proteomics can enable a deeper understanding of disease mechanisms, clinical biomarkers and therapeutic opportunities.
Karsten Suhre , Mark I. McCarthy  & Jochen M. Schwenk